RT Journal Article
SR Electronic
T1 Initiation of subcutaneous infliximab (Remsima) therapy for the treatment of inflammatory bowel disease during the COVID-19 pandemic
JF Frontline Gastroenterology
JO Frontline Gastroenterol
FD BMJ Publishing Group Ltd
SP 89
OP 90
DO 10.1136/flgastro-2020-101760
VO 13
IS 1
A1 McGoran, John
A1 Wilson, Alan
A1 McErlain, Shannan
A1 Kennedy, Noreen
A1 Masterson, Caroline
A1 Collins, Caroline
A1 Morrison, Graham
YR 2022
UL http://fg.bmj.com/content/13/1/89.abstract
AB